Success in a trial of low-intensity ultrasound combined with an amyloid-β antibody represents a major stride towards integrating pharmacological and nonpharmacological approaches to reduce the amyloid-β load in patients with mild Alzheimer disease. This trial also highlights the potential of therapeutic ultrasound modalities to combat neurodegenerative diseases.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Scanning ultrasound-mediated memory and functional improvements do not require amyloid-β reduction
Molecular Psychiatry Open Access 18 March 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Golde, T. E. Open questions for Alzheimer’s disease immunotherapy. Alzheimers Res. Ther. 6, 3 (2014).
Meng, Y., Hynynen, K. & Lipsman, N. Applications of focused ultrasound in the brain: from thermoablation to drug delivery. Nat. Rev. Neurol. 17, 7–22 (2021).
Rezai, A. R. et al. Ultrasound blood-brain barrier opening and aducanumab in Alzheimer’s disease. N. Engl. J. Med. 390, 55–62 (2024).
Leinenga, G., Koh, W. K. & Götz, J. A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease. Alzheimers Res. Ther. 13, 76 (2021).
Kong, C. et al. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model. Transl. Neurodegener. 11, 57 (2022).
Leinenga, G. & Götz, J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model. Sci. Transl. Med. 7, 278ra33 (2015).
Blackmore, D. G. et al. Low-intensity ultrasound restores long-term potentiation and memory in senescent mice through pleiotropic mechanisms including NMDAR signaling. Mol. Psychiatry 26, 6975–6991 (2021).
Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
Hynynen, K., McDannold, N., Vykhodtseva, N. & Jolesz, F. A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220, 640–646 (2001).
Padmanabhan, P. & Götz, J. Clinical relevance of animal models in aging-related dementia research. Nat. Aging 3, 481–493 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Götz, J., Padmanabhan, P. Ultrasound and antibodies — a potentially powerful combination for Alzheimer disease therapy. Nat Rev Neurol 20, 257–258 (2024). https://doi.org/10.1038/s41582-024-00943-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-024-00943-1
This article is cited by
-
Scanning ultrasound-mediated memory and functional improvements do not require amyloid-β reduction
Molecular Psychiatry (2024)